CA2068222A1 - Anticorps monoclonaux - Google Patents
Anticorps monoclonauxInfo
- Publication number
- CA2068222A1 CA2068222A1 CA2068222A CA2068222A CA2068222A1 CA 2068222 A1 CA2068222 A1 CA 2068222A1 CA 2068222 A CA2068222 A CA 2068222A CA 2068222 A CA2068222 A CA 2068222A CA 2068222 A1 CA2068222 A1 CA 2068222A1
- Authority
- CA
- Canada
- Prior art keywords
- rhesus
- antibody molecules
- monoclonal antibodies
- chimeric antibody
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La présente invention décrit des séquences d'ADN encodant des régions, déterminant la complémentarité, de domaines variables d'anticorps humains anti-RhD, et leur emploi dans la production de molécules d'anticorps chimériques de recombinaison.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8925590.5 | 1989-11-13 | ||
GB898925590A GB8925590D0 (en) | 1989-11-13 | 1989-11-13 | Monoclonal antibodies |
PCT/EP1990/001964 WO1991007492A1 (fr) | 1989-11-13 | 1990-11-13 | Anticorps monoclonaux |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2068222A1 true CA2068222A1 (fr) | 1991-05-14 |
CA2068222C CA2068222C (fr) | 1999-05-11 |
Family
ID=10666204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002068222A Expired - Lifetime CA2068222C (fr) | 1989-11-13 | 1990-11-13 | Anticorps monoclonaux |
Country Status (11)
Country | Link |
---|---|
US (2) | US5831063A (fr) |
EP (1) | EP0500659B1 (fr) |
AT (1) | ATE148168T1 (fr) |
AU (1) | AU647054B2 (fr) |
CA (1) | CA2068222C (fr) |
DE (1) | DE69029808T2 (fr) |
DK (1) | DK0500659T3 (fr) |
ES (1) | ES2098274T3 (fr) |
GB (1) | GB8925590D0 (fr) |
GR (1) | GR3022847T3 (fr) |
WO (1) | WO1991007492A1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5495002A (en) * | 1984-01-31 | 1996-02-27 | Akzo N.V. | Tumor associated monoclonal antibody 123AV16 |
GB9020282D0 (en) * | 1990-09-17 | 1990-10-31 | Gorman Scott D | Altered antibodies and their preparation |
US6326488B1 (en) | 1990-10-19 | 2001-12-04 | Board Of Trustees Of University Of Illinois | Gene and genetic elements associated with sensitivity to chemotherapeutic drugs |
US6800738B1 (en) | 1991-06-14 | 2004-10-05 | Genentech, Inc. | Method for making humanized antibodies |
WO1994004679A1 (fr) * | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Procede pour fabriquer des anticorps humanises |
DK0590058T3 (da) | 1991-06-14 | 2004-03-29 | Genentech Inc | Humaniseret heregulin-antistof |
EP0523949B1 (fr) * | 1991-07-15 | 2003-06-25 | The Wellcome Foundation Limited | Production d'anticorps |
FR2724182B1 (fr) * | 1994-09-02 | 1996-12-13 | Pasteur Institut | Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations |
TR199802692T2 (xx) | 1996-06-24 | 1999-03-22 | Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk | Rhesus D antijenleri i�in spesifikli�i olan ba�lay�c� yap�lar olu�turabilen polipeptitler, bunlar� kodlayan DNA ve haz�rlanmalar� i�in i�lem ve kullan�mlar� |
US7323311B2 (en) | 2000-03-03 | 2008-01-29 | Cambridge Antibody Technology Limited | Methods of obtaining a specific binding member that binds eotaxin |
US6946546B2 (en) | 2000-03-06 | 2005-09-20 | Cambridge Antibody Technology Limited | Human antibodies against eotaxin |
FR2807767B1 (fr) | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
SG141239A1 (en) * | 2001-01-26 | 2008-04-28 | Selexis Sa | Matrix attachment regions and methods for use thereof |
WO2003000908A1 (fr) * | 2001-06-21 | 2003-01-03 | Ecole Polytechnique Federale De Lausanne | Procede relatif a l'insertion d'un acide nucleique dans une cellule eucaryote |
US7521053B2 (en) | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US7658924B2 (en) * | 2001-10-11 | 2010-02-09 | Amgen Inc. | Angiopoietin-2 specific binding agents |
GB0324368D0 (en) * | 2003-10-17 | 2003-11-19 | Univ Cambridge Tech | Polypeptides including modified constant regions |
KR101229989B1 (ko) | 2003-10-24 | 2013-02-06 | 셀렉시스 에스. 에이. | Mar 서열의 복합 트랜스펙션 방법에 의한 포유동물 세포에서의 고효율 유전자 전달 및 발현 |
BRPI0820530A2 (pt) * | 2007-11-13 | 2015-06-16 | Boehringer Ingelheim Int | Anticorpos monoclonais que se ligam ao hgm-csf e composições medicinais compreendendo os mesmos |
JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607679D0 (en) * | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
GB8610106D0 (en) * | 1986-04-25 | 1986-05-29 | Central Blood Lab Authority | Human igm-producing heterohybridoma |
AU623345B2 (en) * | 1987-09-18 | 1992-05-14 | National Blood Authority | Human anti-rh(d) monoclonal antibodies |
AU622417B2 (en) * | 1987-09-18 | 1992-04-09 | National Blood Authority | Human anti-rh(d) monoclonal antibodies |
-
1989
- 1989-11-13 GB GB898925590A patent/GB8925590D0/en active Pending
-
1990
- 1990-11-13 ES ES90916718T patent/ES2098274T3/es not_active Expired - Lifetime
- 1990-11-13 DE DE69029808T patent/DE69029808T2/de not_active Expired - Fee Related
- 1990-11-13 WO PCT/EP1990/001964 patent/WO1991007492A1/fr active IP Right Grant
- 1990-11-13 DK DK90916718.1T patent/DK0500659T3/da active
- 1990-11-13 US US07/856,034 patent/US5831063A/en not_active Expired - Lifetime
- 1990-11-13 EP EP90916718A patent/EP0500659B1/fr not_active Expired - Lifetime
- 1990-11-13 AT AT90916718T patent/ATE148168T1/de not_active IP Right Cessation
- 1990-11-13 AU AU67214/90A patent/AU647054B2/en not_active Ceased
- 1990-11-13 CA CA002068222A patent/CA2068222C/fr not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/477,553 patent/US5919910A/en not_active Expired - Lifetime
-
1997
- 1997-03-17 GR GR970400522T patent/GR3022847T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GB8925590D0 (en) | 1990-01-04 |
ATE148168T1 (de) | 1997-02-15 |
CA2068222C (fr) | 1999-05-11 |
US5919910A (en) | 1999-07-06 |
WO1991007492A1 (fr) | 1991-05-30 |
US5831063A (en) | 1998-11-03 |
DK0500659T3 (da) | 1997-07-14 |
ES2098274T3 (es) | 1997-05-01 |
AU647054B2 (en) | 1994-03-17 |
EP0500659A1 (fr) | 1992-09-02 |
AU6721490A (en) | 1991-06-13 |
DE69029808T2 (de) | 1997-07-10 |
GR3022847T3 (en) | 1997-06-30 |
DE69029808D1 (de) | 1997-03-06 |
EP0500659B1 (fr) | 1997-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2068222A1 (fr) | Anticorps monoclonaux | |
WO2002020569A3 (fr) | Genes mammaliens, reactifs et methodes associes | |
WO1998050433A3 (fr) | Anticorps monoclonaux humains contre le recepteur du facteur de croissance epidermique | |
UA29494C2 (uk) | Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція | |
AU2821195A (en) | Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin | |
MY145191A (en) | Human antibodies that bind human il-12 and methods for producing | |
BR9507594B1 (pt) | anticorpo monoclonal com scfv humanizado, molécula de ácido nucleico recombinante e proteìna recombinante. | |
WO2001090358A3 (fr) | Proteines de recepteurs de mammiferes, reactifs et procedes apparentes | |
GB8806339D0 (en) | Monoclonal antibodies | |
IL162117A0 (en) | Humanized collagen antibodies and methods utilizing the same | |
EP1433792A8 (fr) | Protéines réceptrices humaines, réactifs et méthodes associés | |
IL116617A0 (en) | Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples | |
NZ333329A (en) | Polypeptides capable of forming antigen binding structures with specificity for rhesus d antigens | |
ATE370235T1 (de) | Rekombinantpeptide hergeleitet vom mc3 antikörper gegen ba46, verfahren zu deren verwendung und verfahren zur humanisierung von antikörperpeptiden | |
WO2001036467A3 (fr) | Proteines de recepteurs mammaliens, reactifs et procedes s'y rapportant | |
WO2002074251A3 (fr) | Traitement par anticorps monoclonal du cancer du pancreas | |
WO1999046379A3 (fr) | Proteines receptrices humaines; reactifs et procedes associes | |
WO2001057219A3 (fr) | Cytokines mammaliennes, leurs recepteurs, reactifs et procedes correspondants | |
EP0972054A4 (fr) | Amelioration de la reaction immune au moyen de molecules de ciblage | |
EP1434799A4 (fr) | Molecules d'adn et molecules d'adn de recombinaison pour l'elaboration d'anticorps monoclonaux humanises vis-a-vis de s.mutans | |
NO179328C (no) | Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom | |
EP0723663A4 (fr) | Hybridome et anticorps monoclonal humanise anti kc-4, adn et arn codant ce dernier, trousse, et procedes diagnostiques et therapeutiques | |
WO2002000005A8 (fr) | Banques presentant des fragments d'anticorps humains avec des regions determinant une complementarite hybride | |
WO2001002429A3 (fr) | Angiopoietine 6 et ses utilisations | |
WO2000017363A3 (fr) | MOLECULE DU TYPE INTERLEUKINE-1: INTERLEUKINE-1z, ACIDES NUCLEIQUES, POLYPEPTIDES, ANTICORPS ET LEURS APPLICATIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed | ||
MKEC | Expiry (correction) |
Effective date: 20121202 |